A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension

Robyn J. Barst*, Lewis J. Rubin, Walker A. Long, Michael D. Mcgoon, Stuart Rich, David B. Badesch, Bertron M. Groves, Victor F. Tapson, Robert C. Bourge, Bruce H. Brundage, Spencer K. Koerner, David Langleben, Cesar A. Keller, Srinivas Murali, Barry F. Uretsky, Linda M. Clayton, Maria M. Jöbsis, Shelmer D. Blackburn, Denise Shortino, James W. Crow

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

2493 Scopus citations

Fingerprint

Dive into the research topics of 'A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science